The American Heart Association, the American College of Cardiology, and the Heart Failure Society of America updated their guideline for the management of heart failure in 2022. Which of the following statements is an important takeaway from this new guideline?
The American Heart Association and the American College of Cardiology, with the Heart Failure Society of America, recently updated their joint practice guideline for the management of heart failure. Most notable in their top take-home messages is the inclusion of SGLT2i, which are recommended in all classes of heart failure, including the prevention of heart failure in at-risk patients. Three other medication categories given class 1A recommendation in the management of heart failure with reduced ejection fraction (HFrEF) include:
SGLT2i are a new class of oral hypoglycemics initially used to help lower blood sugar in patients with type 2 diabetes by reducing the reabsorption of sodium and glucose at the...
